Abacus Life Inc. (ABL)
Abacus Life Statistics
Share Statistics
Abacus Life has 96.85M shares outstanding. The number of shares has increased by 28.03% in one year.
| Shares Outstanding | 96.85M |
| Shares Change (YoY) | 28.03% |
| Shares Change (QoQ) | 2.93% |
| Owned by Institutions (%) | 35.78% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 77 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -24.41 and the forward PE ratio is 8.54. Abacus Life's PEG ratio is 0.08.
| PE Ratio | -24.41 |
| Forward PE | 8.54 |
| PS Ratio | 0 |
| Forward PS | 3.4 |
| PB Ratio | 1.38 |
| P/FCF Ratio | -2.79 |
| PEG Ratio | 0.08 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Abacus Life.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.55, with a Debt / Equity ratio of 0.91.
| Current Ratio | 2.55 |
| Quick Ratio | 2.55 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.84 |
| Interest Coverage | 533606.05 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $712,890,356,687.9 |
| Profits Per Employee | $-152,618.15 |
| Employee Count | 157 |
| Asset Turnover | 128035.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 5.48M |
| Effective Tax Rate | -28.22% |
Stock Price Statistics
The stock price has increased by -30.72% in the last 52 weeks. The beta is 0.15, so Abacus Life's price volatility has been higher than the market average.
| Beta | 0.15 |
| 52-Week Price Change | -30.72% |
| 50-Day Moving Average | 7.65 |
| 200-Day Moving Average | 8.59 |
| Relative Strength Index (RSI) | 59.64 |
| Average Volume (20 Days) | 326,852 |
Income Statement
In the last 12 months, Abacus Life had revenue of 111,923.8B and earned -23.96M in profits. Earnings per share was -0.32.
| Revenue | 111,923.8B |
| Gross Profit | 100,552.1B |
| Operating Income | 9,754.2B |
| Net Income | -23.96M |
| EBITDA | 9,754.2B |
| EBIT | -1.15M |
| Earnings Per Share (EPS) | -0.32 |
Balance Sheet
The company has 131.94M in cash and 385.91M in debt, giving a net cash position of -253.97M.
| Cash & Cash Equivalents | 131.94M |
| Total Debt | 385.91M |
| Net Cash | -253.97M |
| Retained Earnings | -57.9M |
| Total Assets | 874.16M |
| Working Capital | 97.1M |
Cash Flow
In the last 12 months, operating cash flow was -208.81M and capital expenditures -805.14K, giving a free cash flow of -209.62M.
| Operating Cash Flow | -208.81M |
| Capital Expenditures | -805.14K |
| Free Cash Flow | -209.62M |
| FCF Per Share | -2.81 |
Margins
Gross margin is 89.84%, with operating and profit margins of 8.71% and 0%.
| Gross Margin | 89.84% |
| Operating Margin | 8.71% |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | 8.71% |
| EBIT Margin | 8.71% |
| FCF Margin | n/a |
Dividends & Yields
ABL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ABL is $13.5, which is 64% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.5 |
| Price Target Difference | 64% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Scores
| Altman Z-Score | 1.21 |
| Piotroski F-Score | 1 |